Filter Results:
(1,563)
Show Results For
- All HBS Web
(2,161)
- People (2)
- News (469)
- Research (1,563)
- Events (1)
- Multimedia (13)
- Faculty Publications (1,187)
Show Results For
- All HBS Web
(2,161)
- People (2)
- News (469)
- Research (1,563)
- Events (1)
- Multimedia (13)
- Faculty Publications (1,187)
Sort by
- 2010
- Chapter
The Many Faces of Nonprofit Accountability
By: Alnoor Ebrahim
Calls for greater accountability are not new. Leaders of organizations, be they nonprofit, business, or government, face a constant stream of demands from various constituents demanding accountable behavior. But what does it mean to be accountable? By and large,... View Details
Keywords: Crime and Corruption; Corporate Accountability; Governing Rules, Regulations, and Reforms; Taxation; Leadership; Management; Nonprofit Organizations; Behavior; Trust
Ebrahim, Alnoor. "The Many Faces of Nonprofit Accountability." Chap. 4 in The Jossey-Bass Handbook of Nonprofit Leadership and Management. 3rd ed. Edited by David O. Renz, 110–121. San Francisco: Jossey-Bass, 2010.
- November 2009 (Revised July 2011)
- Case
International Lobbying and The Dow Chemical Company (A)
By: Arthur A. Daemmrich
This case explores company strategy, business-government relations, and collective action challenges associated with international and domestic lobbying regarding regulation of the chemical industry. In the fall of 2006, a five-year legislative process for a major new... View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Business and Government Relations; Power and Influence; Competitive Advantage; Corporate Strategy; Chemical Industry; Manufacturing Industry; Europe
Daemmrich, Arthur A. "International Lobbying and The Dow Chemical Company (A)." Harvard Business School Case 710-027, November 2009. (Revised July 2011.)
- 2008
- Chapter
The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA-Typing Companies
By: Arthur A. Daemmrich
During the past 15 years, new biotechnology companies have promoted DNA typing as a sophisticated criminal and paternity identification technique. Private testing laboratories produce results that link individuals with crime scenes and fathers to their children.... View Details
- 2007
- Book
Perspectives on Risk and Regulation: The FDA at 100
By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
- 23 Nov 2010
- First Look
First Look: November 23
repeatedly declared fiscal emergencies as California's state budget deficit reached all-time highs. The Governor and legislative leaders established the Commission on the Twenty-first Century Economy to recommend tax reforms that would... View Details
Keywords: Sean Silverthorne
- 02 Sep 2013
- Research & Ideas
The Curse of Double-Digit Growth
found that natural resource exports were a crucial driver in 17 of the incidents of high growth, while 13 were pushed along by political reforms or economic diversification, most of which were temporary. Nine featured foreign aid and... View Details
Keywords: by Kim Girard
- 20 Feb 2001
- Research & Ideas
What’s Next for Japan
whether Japan should take on competition-oriented policies, or the more traditional policies that protect the strong social traditions of Japanese big business. He recommended watching the reformation of the Japanese telecom monopoly,... View Details
Keywords: by Hilah Geer
- 27 Dec 2010
- Research & Ideas
HBS Faculty on 2010’s Biggest Business Developments
each year in personal and corporate taxes (excluding social security and Medicare taxes) is only a bit over $1 trillion. Spending must be cut. The recent report of The National Commission on Fiscal Responsibility and Reform suggested a... View Details
Keywords: by Staff
- 06 Feb 2006
- Research & Ideas
The Trouble Behind Livedoor
has researched stock price manipulation in Japan and looked specifically at firms like Livedoor. He says the Livedoor episode may, in the end, do some good by paving the road for reform of Japan's "abysmal" corporate governance.... View Details
- 2024
- Working Paper
Prozac—Controversial Blockbuster: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes the development of Prozac, a blockbuster drug that transformed
the treatment of depression – and became a cultural phenomenon in the United States. Specifically, we
chronicle the: 1) prior treatments for depression and the research that... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Prozac—Controversial Blockbuster: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-135, July 2020. (Revised May 2024.)
- 2024
- Working Paper
Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised May 2024.)
- April 2008
- Teaching Note
Viagen: Revolutioning the Livestock Industry (TN)
By: David E. Bell, Mary L. Shelman and Eliot Sherman
Teaching Note for [507021]. View Details
- 2012
- Other Unpublished Work
What Are We Meeting For? The Consequences of Private Meetings with Investors
By: Eugene F. Soltes and David H. Solomon
Executives of publicly-traded firms spend considerable time meeting privately with investors, despite regulation restricting their ability to convey material nonpublic information. Using a set of records of all one-on-one meetings between senior management and... View Details
Keywords: Decision Choices and Conditions; Investment; Investment Funds; Governing Rules, Regulations, and Reforms; Management Teams; Public Ownership; Business and Shareholder Relations
Soltes, Eugene F., and David H. Solomon. "What Are We Meeting For? The Consequences of Private Meetings with Investors." September 2012.
- November 2024
- Background Note
Nonprofit Governance: Some Basics
By: Lynn S. Paine and Will Hurwitz
This background note discusses basics about the prevalence, purpose, and unique legal, governance and regulatory dynamics of nonprofits and their boards of directors. The note describes both similarities and differences between for-profit and non-profit governance,... View Details
Keywords: Corporate Governance; Leadership; Mission and Purpose; Nonprofit Organizations; Governing Rules, Regulations, and Reforms; Governing and Advisory Boards; United States
Paine, Lynn S., and Will Hurwitz. "Nonprofit Governance: Some Basics." Harvard Business School Background Note 325-067, November 2024.
- March 2022 (Revised September 2022)
- Case
Can Papaya Global Keep Scaling Fast?
By: Daniel Isenberg and William R. Kerr
Companies that employ people all around the world also need to pay those people. That can be an exceedingly complex task, though - defining terms of employment, complying with global regulations, and working with huge quantities of data, among other obstacles,... View Details
Keywords: Entrepreneurship; Scaling And Growth; Job Design and Levels; Compensation and Benefits; Governing Rules, Regulations, and Reforms; Global Range
Isenberg, Daniel, and William R. Kerr. "Can Papaya Global Keep Scaling Fast?" Harvard Business School Case 222-072, March 2022. (Revised September 2022.)
- June 2012 (Revised August 2012)
- Case
MF Global: Where's the Money?
By: Clayton S. Rose, Pamela Chan and Raghav Chopra
When MF Global failed in October of 2011, it was discovered that $1.6 billion of segregated customer assets was missing. Safeguarding these assets was the firm's responsibility, and in the words of one SEC official, its "sacred obligation." What is known about the... View Details
Keywords: Financial Firms; Customer Obligations; Bankruptcy; Regulation; Financial Crisis; Brokerage; Asset Management; Ethics; Governing Rules, Regulations, and Reforms; Financial Management; Crisis Management; Insolvency and Bankruptcy; Financial Services Industry
Rose, Clayton S., Pamela Chan, and Raghav Chopra. "MF Global: Where's the Money?" Harvard Business School Case 312-106, June 2012. (Revised August 2012.)
- August 2009 (Revised January 2012)
- Case
Pandora: Royalties Kill the Web Radio Star? (A)
By: Robert C. Pozen and Alex Curtis Rosenfeld
Joe Kennedy, president and CEO of Pandora, one of the largest and most popular web (Internet) radio broadcasters, had just received bad news. The Copyright Royalty Board (CRB) had announced its decision to increase the royalties required to be paid by the web radio... View Details
Keywords: Profit; Governing Rules, Regulations, and Reforms; Copyright; Laws and Statutes; Rights; Internet and the Web; Media and Broadcasting Industry
Pozen, Robert C., and Alex Curtis Rosenfeld. "Pandora: Royalties Kill the Web Radio Star? (A)." Harvard Business School Case 310-026, August 2009. (Revised January 2012.)
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- November 2007 (Revised March 2008)
- Case
Tyco International: Corporate Governance
By: Rakesh Khurana and James Weber
Examines how Tyco and its board recovered from its corporate scandals. Describes how its CEO and board set out to institute processes, guidelines, and a culture that would make Tyco into a company widely recognized for its world class corporate governance. View Details
Keywords: Crime and Corruption; Corporate Governance; Governing Rules, Regulations, and Reforms; Governing and Advisory Boards; Business Processes; Organizational Culture
Khurana, Rakesh, and James Weber. "Tyco International: Corporate Governance." Harvard Business School Case 408-059, November 2007. (Revised March 2008.)
- November 1991
- Case
Monsanto's March into Biotechnology (B)
Monsanto has yet to receive FDA approval for BST, a growth hormone for cows. Anti-BST groups have successfully lobbied Wisconsin and Minnesota, major milk producing states, to ban milk from BST-injected cows; the FDA has charged Monsanto with improperly promoting BST... View Details
Keywords: Animal-Based Agribusiness; Safety; Food; Governing Rules, Regulations, and Reforms; Law Enforcement; Conflict and Resolution; Research and Development; Technology; Agriculture and Agribusiness Industry; Biotechnology Industry; Minnesota; Wisconsin
Leonard, Dorothy A. "Monsanto's March into Biotechnology (B)." Harvard Business School Case 692-066, November 1991.